Discovery of novel pyrido-pyrrolidine hybrid compounds as alpha-glucosidase inhibitors and alternative agent for control of type 1 diabetes.
A new library of pyrido-pyrrolidine hybrid compounds were designed, developed and screened for their antidiabetic property with alpha-glucosidase. The design is based on preliminary screening of key fragments identified from literature reported alpha-gluc..... Read More